FDA Authorized Johnson & Johnson Surgical Robot

The Ottava system earned De Novo authorization in July 2026 for use in 10 distinct general surgery procedures.

Updated on Sept. 28, 2026 in Robotics

Isometric editorial illustration of a robotic surgical arm attached to a minimalist white operating table in a sterile room. — The FDA granted De Novo authorization to Johnson & Johnson's Ottava surgical system, a robotic platform featuring four arms integrated into a surgical table. AI Illustration. Upload story photo >

Live Poll

Do you believe new robotic surgical technology improves care and hospital efficiency in your community?

In July 2026, the FDA granted De Novo authorization to the Johnson & Johnson Ottava surgical system. The technology features four robotic arms integrated directly into a standard surgical table.

Why it matters

The system design aims to provide operating rooms with increased flexibility by reducing the physical footprint required for robotic surgery. This allows surgical teams to operate with more space compared to traditional boom- or cart-mounted systems.

The Ottava system occupies 30% to 50% less space than competing robotic systems. Each of the four robotic arms features nine motorized joints with 540 degrees of articulation and a seven-degree-of-freedom haptic interface.

The players

Johnson & Johnson

Headquartered in New Brunswick, New Jersey, this multinational corporation develops medical devices, pharmaceuticals, and consumer health products.

Intuitive Surgical

Based in Sunnyvale, California, this organization is a leader in the development of robotic-assisted surgical systems like the da Vinci platform.

The details

The platform utilizes Twin Motion technology to synchronize the movement of the surgical table and the robotic arms, which move into position automatically at the push of a button. Johnson & Johnson is also developing reimagined Ethicon laparoscopic instruments to integrate with the new hardware.

July 2026: The FDA granted De Novo authorization to the Ottava surgical system.

Heart Disease
Sept. 29
FDA Cleared KARL STORZ Cardiac Endoscope
Artificial Intelligence
Sept. 21
FDA Cleared New AI Tool for CT Scan Triage
Robotics
Sept. 18
Figure AI Tested Humanoid Robot in Unfamiliar Homes

The Tech Race

This development challenges the established robotic-assisted surgery market by replacing bulky external equipment with a streamlined, integrated design. It positions Johnson & Johnson to compete more effectively against dominant incumbents by offering a smaller surgical footprint.

Surgeons will gain more physical space and flexibility within the operating room due to the reduced equipment footprint. Hospital systems may also benefit from the automated positioning of the arms, which can improve procedure workflows for the medical staff.

The takeaway

The move toward table-integrated robotics reflects a broader trend toward maximizing limited space in high-tech medical environments. Providers looking to adopt this technology should consider the specific training requirements for the new hand-control interface and multi-jointed arms.